Marcel de Brito van Velze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcel de Brito van Velze has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Carmen B. Schäfer
Affiliation Department of Neuroscience, Erasmus Medical Center, Rotterdam, The Netherlands
1 shared publication- Geeske M. van Woerden
Erasmus MC
1 shared publication - Linda M. C. Koene
Affiliations Department of Neuroscience, Erasmus Medical Center, Rotterdam, the Netherlands, The ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, Rotterdam, the Netherlands
1 shared publication Mark Nellist
Affiliation Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, Zuid Holland, the Netherlands
1 shared publication- Martina Proietti Onori
The ENCORE Expertise Center for Neurodevelopmental Disorders
1 shared publication - Ype Elgersma
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 26 May 2021
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 19 (5) , e3001279
RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity
Hyperactivation of the mammalian target of rapamycin (mTOR) pathway can cause malformation of cortical development (MCD) with associated epilepsy and intellectual disability (ID) through a yet unknown mechanism. Here, we made use of the recently identified dominant-active mutation inRas Homolog Enriched in Brain 1(RHEB), RHEBp.P37L, to gain insight in the mechanism underlying the epilepsy caused by hyperactivation of the mTOR pathway. Focal expression of RHEBp.P37L in mouse somatosensory cortex (SScx) results in an MCD-like phenotype, with increased mTOR signaling, ectopic localization of neurons, and reliable generalized seizures. We show that in this model, the mTOR-dependent seizures are caused by enhanced axonal connectivity, causing hyperexcitability of distally connected neurons. Indeed, blocking axonal vesicle release from the RHEBp.P37L neurons alone completely stopped the seizures and normalized the hyperexcitability of the distally connected neurons. These results provide new evidence of the extent of anatomical and physiological abnormalities caused by mTOR hyperactivity, beyond local malformations, which can lead to generalized epilepsy.
- 26 May 2021
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 19 (5) , e3001279
Open AccessRHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity
Hyperactivation of the mammalian target of rapamycin (mTOR) pathway can cause malformation of cortical development (MCD) with associated epilepsy and intellectual disability (ID) through a yet unknown mechanism. Here, we made use of the recently identified dominant-active mutation inRas Homolog Enriched in Brain 1(RHEB), RHEBp.P37L, to gain insight in the mechanism underlying the epilepsy caused by hyperactivation of the mTOR pathway. Focal expression of RHEBp.P37L in mouse somatosensory cortex (SScx) results in an MCD-like phenotype, with increased mTOR signaling, ectopic localization of neurons, and reliable generalized seizures. We show that in this model, the mTOR-dependent seizures are caused by enhanced axonal connectivity, causing hyperexcitability of distally connected neurons. Indeed, blocking axonal vesicle release from the RHEBp.P37L neurons alone completely stopped the seizures and normalized the hyperexcitability of the distally connected neurons. These results provide new evidence of the extent of anatomical and physiological abnormalities caused by mTOR hyperactivity, beyond local malformations, which can lead to generalized epilepsy.